Members |
acceptabilityId |
3,5,3'5' tetraiodothyroacetic acid |
Acceptable (foundation metadata concept) |
3,5,3'5' tetraiodothyronine |
Acceptable (foundation metadata concept) |
3,5-di-tert-butyl-4-hydroxybenzyl alcohol |
Preferred (foundation metadata concept) |
3,5-di-tert-butyl-4-hydroxybenzyl alcohol (substance) |
Preferred (foundation metadata concept) |
3,5-dihydroxybenzoic acid |
Preferred (foundation metadata concept) |
3,5-dihydroxybenzoic acid (substance) |
Preferred (foundation metadata concept) |
3,5-dinitrotyrosine aminotransferase |
Acceptable (foundation metadata concept) |
3,6-epoxytetradecanedioic acid |
Preferred (foundation metadata concept) |
3,6-epoxytetradecanedioic acid (substance) |
Preferred (foundation metadata concept) |
3,7,11-trimethyl-2,6,10-dodecatrien-1-ol |
Acceptable (foundation metadata concept) |
3,7-dimethylquercetin 4'-O-methyltransferase |
Preferred (foundation metadata concept) |
3,7-dimethylquercetin 4'-O-methyltransferase (substance) |
Preferred (foundation metadata concept) |
3,9-dihydroxypterocarpan 6A-hydroxylase |
Acceptable (foundation metadata concept) |
3,9-dihydroxypterocarpan 6A-monooxygenase |
Preferred (foundation metadata concept) |
3,9-dihydroxypterocarpan 6A-monooxygenase (substance) |
Preferred (foundation metadata concept) |
3-(3,4-dichlorophenyl)-1,1-dimethylurea |
Acceptable (foundation metadata concept) |
3-(3-hydroxyphenyl) propanoic acid |
Preferred (foundation metadata concept) |
3-(3-hydroxyphenyl) propanoic acid (substance) |
Preferred (foundation metadata concept) |
3-(4-chlorophenyl)-1, 1-dimethyl urea |
Acceptable (foundation metadata concept) |
3-(4-methylbenzylidene)-camphor |
Preferred (foundation metadata concept) |
3-(4-methylbenzylidene)-camphor (substance) |
Preferred (foundation metadata concept) |
3-(4-tert-butylphenyl)-2-methylpropanal |
Acceptable (foundation metadata concept) |
3-(dimethylaminomethyl)indole |
Acceptable (foundation metadata concept) |
3-(imidazol-5-yl)lactate dehydrogenase |
Preferred (foundation metadata concept) |
3-(imidazol-5-yl)lactate dehydrogenase (substance) |
Preferred (foundation metadata concept) |
3-(p-Chlorophenyl)-1, 1-dimethyl urea |
Preferred (foundation metadata concept) |
3-(p-Chlorophenyl)-1, 1-dimethyl urea (substance) |
Preferred (foundation metadata concept) |
3-(p-chlorophenyl)-1, 1-dimethyl urea |
Acceptable (foundation metadata concept) |
3-10 centile |
Preferred (foundation metadata concept) |
3-10 centile (qualifier value) |
Preferred (foundation metadata concept) |
3-3'dichlorobenzidine |
Preferred (foundation metadata concept) |
3-3'dichlorobenzidine (substance) |
Preferred (foundation metadata concept) |
3-4 hourly |
Acceptable (foundation metadata concept) |
3-4 times a week |
Acceptable (foundation metadata concept) |
3-4x /day |
Acceptable (foundation metadata concept) |
3-4x /wk |
Acceptable (foundation metadata concept) |
3-Aminoisobutyrate measurement |
Preferred (foundation metadata concept) |
3-Aminoisobutyrate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency |
Preferred (foundation metadata concept) |
3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency (disorder) |
Preferred (foundation metadata concept) |
3-Dimensional |
Acceptable (foundation metadata concept) |
3-He |
Acceptable (foundation metadata concept) |
3-Hydroxy isovaleric acid |
Preferred (foundation metadata concept) |
3-Hydroxy isovaleric acid (substance) |
Preferred (foundation metadata concept) |
3-Hydroxy,3-methylglutarate measurement |
Preferred (foundation metadata concept) |
3-Hydroxy,3-methylglutarate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitor adverse reaction |
Acceptable (foundation metadata concept) |
3-Hydroxy-3-methylglutaryl coenzyme A lyase |
Preferred (foundation metadata concept) |
3-Hydroxy-3-methylglutaryl coenzyme A lyase (substance) |
Preferred (foundation metadata concept) |
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor adverse reaction |
Acceptable (foundation metadata concept) |
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor adverse reaction (disorder) |
Preferred (foundation metadata concept) |
3-Hydroxy-3-methylglutaryl-CoA lyase |
Acceptable (foundation metadata concept) |
3-Hydroxy-3-methylglutaryl-CoA lyase deficiency |
Acceptable (foundation metadata concept) |
3-Hydroxy-3-methylglutaryl-CoA lyase deficiency |
Acceptable (foundation metadata concept) |
3-Hydroxy-3-methylglutaryl-coenzyme A (HMG CoA) reductase inhibitor allergy |
Acceptable (foundation metadata concept) |
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor allergy |
Acceptable (foundation metadata concept) |
3-Hydroxyadipate measurement |
Preferred (foundation metadata concept) |
3-Hydroxyadipate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxybutanoate |
Acceptable (foundation metadata concept) |
3-Hydroxybutylcarnitine |
Preferred (foundation metadata concept) |
3-Hydroxybutylcarnitine (substance) |
Preferred (foundation metadata concept) |
3-Hydroxybutylcarnitine measurement |
Preferred (foundation metadata concept) |
3-Hydroxybutylcarnitine measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxybutyrate + acetoacetate |
Preferred (foundation metadata concept) |
3-Hydroxybutyrate + acetoacetate (substance) |
Preferred (foundation metadata concept) |
3-Hydroxybutyrate + gamma aminobutyric acid |
Preferred (foundation metadata concept) |
3-Hydroxybutyrate + gamma aminobutyric acid (substance) |
Preferred (foundation metadata concept) |
3-Hydroxybutyrate dehydrogenase |
Preferred (foundation metadata concept) |
3-Hydroxybutyrate dehydrogenase (substance) |
Preferred (foundation metadata concept) |
3-Hydroxybutyrate measurement |
Preferred (foundation metadata concept) |
3-Hydroxybutyrate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxybutyrylcarnitine + malonylcarnitine |
Preferred (foundation metadata concept) |
3-Hydroxybutyrylcarnitine + malonylcarnitine (substance) |
Preferred (foundation metadata concept) |
3-Hydroxydodecanedioate measurement |
Preferred (foundation metadata concept) |
3-Hydroxydodecanedioate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxyglutarate measurement |
Preferred (foundation metadata concept) |
3-Hydroxyglutarate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxyhexanoylcarnitine + glutarylcarnitine |
Preferred (foundation metadata concept) |
3-Hydroxyhexanoylcarnitine + glutarylcarnitine (substance) |
Preferred (foundation metadata concept) |
3-Hydroxyisobutyrate measurement |
Preferred (foundation metadata concept) |
3-Hydroxyisobutyrate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxyisobutyric aciduria |
Preferred (foundation metadata concept) |
3-Hydroxyisobutyric aciduria (disorder) |
Preferred (foundation metadata concept) |
3-Hydroxyisovalerylcarnitine + 2-methyl,3-hydroxybutyrylcarnitine |
Preferred (foundation metadata concept) |
3-Hydroxyisovalerylcarnitine + 2-methyl,3-hydroxybutyrylcarnitine (substance) |
Preferred (foundation metadata concept) |
3-Hydroxyisovalerylcarnitine + methylmalonylcarnitine |
Preferred (foundation metadata concept) |
3-Hydroxyisovalerylcarnitine + methylmalonylcarnitine (substance) |
Preferred (foundation metadata concept) |
3-Hydroxyisovalerylcarnitine measurement |
Preferred (foundation metadata concept) |
3-Hydroxyisovalerylcarnitine measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxylinoleoylcarnitine measurement |
Preferred (foundation metadata concept) |
3-Hydroxylinoleoylcarnitine measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxyoctanoylcarnitine + malonylcarnitine |
Preferred (foundation metadata concept) |
3-Hydroxyoctanoylcarnitine + malonylcarnitine (substance) |
Preferred (foundation metadata concept) |
3-Hydroxyoleoylcarnitine measurement |
Preferred (foundation metadata concept) |
3-Hydroxyoleoylcarnitine measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxypalmitoylcarnitine measurement |
Preferred (foundation metadata concept) |
3-Hydroxypalmitoylcarnitine measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxypropionate measurement |
Preferred (foundation metadata concept) |
3-Hydroxypropionate measurement (procedure) |
Preferred (foundation metadata concept) |
3-Hydroxysebacate measurement |
Preferred (foundation metadata concept) |
3-Hydroxysebacate measurement (procedure) |
Preferred (foundation metadata concept) |